drugset / Trial / NCT01879527

Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve

NCT01879527

Phase 2 Unknown 78 enrolled Medical University of Vienna
RandomizedParallel-groupTriple-blindTreatment

Summary

Following acute inflammation of the optic nerve region, as commonly seen in multiple sclerosis patients, the optic nerve often undergoes atrophy, thus representing permanent damage. Data from animal studies suggest that amiloride may prevent this process. The aim of this study is to assess a potential neuroprotective effect of amiloride in acute autoimmune inflammation of the optic nerve region.

Timeline

Start
2014-03
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amiloride Small molecule 8.64 mg Oral
Comparator Hydrochlorothiazide Unknown 100 mg Oral

Indications